XML 48 R39.htm IDEA: XBRL DOCUMENT v3.22.2
Stock Based Compensation - Summary of RSU Activity (Detail) - RSUs [Member]
6 Months Ended
Jun. 30, 2022
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]  
Unvested Shares, Beginning Balance | shares 3,936,892
Granted | shares 3,255,385
Vested and issued | shares (416,525)
Cancelled | shares (883,482)
Unvested Shares, Ending Balance | shares 5,892,270
Weighted Average Grant Date Fair Value, Beginning Balance | $ / shares $ 11.50
Weighted Average Grant Date Fair Value, Granted | $ / shares 7.43
Weighted Average Grant Date Fair Value, Vested and issued | $ / shares 12.18
Weighted Average Grant Date Fair Value, Cancelled | $ / shares 11.15
Weighted Average Grant Date Fair Value, Ending Balance | $ / shares $ 9.26
Service Based Restricted Stock Units [Member]  
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]  
Unvested Shares, Beginning Balance | shares 2,915,720
Granted | shares 2,755,385
Vested and issued | shares (416,525)
Cancelled | shares (599,184)
Unvested Shares, Ending Balance | shares 4,655,396
Weighted Average Grant Date Fair Value, Beginning Balance | $ / shares $ 11.66
Weighted Average Grant Date Fair Value, Granted | $ / shares 7.31
Weighted Average Grant Date Fair Value, Vested and issued | $ / shares 12.18
Weighted Average Grant Date Fair Value, Cancelled | $ / shares 10.37
Weighted Average Grant Date Fair Value, Ending Balance | $ / shares $ 9.21
Performance Based Restricted Stock Units [Member]  
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]  
Unvested Shares, Beginning Balance | shares 1,021,172
Granted | shares 500,000
Cancelled | shares (284,298)
Unvested Shares, Ending Balance | shares 1,236,874
Weighted Average Grant Date Fair Value, Beginning Balance | $ / shares $ 11.04
Weighted Average Grant Date Fair Value, Granted | $ / shares 8.11
Weighted Average Grant Date Fair Value, Cancelled | $ / shares 12.80
Weighted Average Grant Date Fair Value, Ending Balance | $ / shares $ 9.46